Qube Research & Technologies (QRT)
SBFM

Qube Research & Technologies (QRT)’s Sunshine Biopharma SBFM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8
Closed -$638 – 4001
2024
Q2 		$638 Buy
+8
New +$3.81K ﹤0.01% 3300

Other funds holding SBFM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SBFM Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Sunshine Biopharma (SBFM) in Q3 2024, closing a stake of 8 shares — an estimated $638 sold.

Qube Research & Technologies (QRT) first reported a position in SBFM in Q2 2024 and held it in 1 quarter. The position peaked at $638 in Q2 2024. 3 funds tracked by Wall St. Rank hold SBFM as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Sunshine Biopharma position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 8 Sunshine Biopharma shares in Q3 2024, an estimated $638.
  • Qube Research & Technologies (QRT) first reported a position in Sunshine Biopharma in Q2 2024 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Sunshine Biopharma position peaked at $638 in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.